End-of-day quote
Korea S.E.
18:00:00 2024-05-19 EDT
|
5-day change
|
1st Jan Change
|
15,020
KRW
|
-3.28%
|
|
+2.04%
|
-10.86%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
363,525
|
326,259
|
326,259
|
-
|
Enterprise Value (EV)
2 |
363.5
|
284.6
|
244.3
|
274.3
|
P/E ratio
|
-
|
-22.7
x
|
-33
x
|
-36.5
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1,818
x
|
-
|
14.5
x
|
24.2
x
|
EV / Revenue
|
1,818
x
|
-
|
10.9
x
|
20.3
x
|
EV / EBITDA
|
-
|
-22.4
x
|
37.6
x
|
-91.4
x
|
EV / FCF
|
-
|
241
x
|
-40.7
x
|
-14.1
x
|
FCF Yield
|
-
|
0.41%
|
-2.46%
|
-7.11%
|
Price to Book
|
-
|
5.61
x
|
4.66
x
|
4.89
x
|
Nbr of stocks (in thousands)
|
21,574
|
21,722
|
21,722
|
-
|
Reference price
3 |
16,850
|
15,020
|
15,020
|
15,020
|
Announcement Date
|
4/27/23
|
3/12/24
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
0.2
|
-
|
22.5
|
13.5
|
EBITDA
1 |
-
|
-12.71
|
6.5
|
-3
|
EBIT
1 |
-
|
-13.39
|
6
|
-3.5
|
Operating Margin
|
-
|
-
|
26.67%
|
-25.93%
|
Earnings before Tax (EBT)
1 |
-
|
-14.13
|
-10
|
-9
|
Net income
1 |
-8.959
|
-14.13
|
-10
|
-9
|
Net margin
|
-4,479.64%
|
-
|
-44.44%
|
-66.67%
|
EPS
2 |
-
|
-662.0
|
-455.0
|
-411.0
|
Free Cash Flow
3 |
-
|
1,000
|
-6,000
|
-19,500
|
FCF margin
|
-
|
-
|
-26,666.67%
|
-144,444.44%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/23
|
3/12/24
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
41.6
|
82
|
52
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
-
|
1,000
|
-6,000
|
-19,500
|
ROE (net income / shareholders' equity)
|
-
|
-22.3%
|
9.8%
|
-6.15%
|
ROA (Net income/ Total Assets)
|
-
|
-18.7%
|
6.75%
|
-4.35%
|
Assets
1 |
-
|
75.4
|
-148.1
|
206.9
|
Book Value Per Share
3 |
-
|
2,677
|
3,220
|
3,072
|
Cash Flow per Share
3 |
-
|
-471.0
|
-442.0
|
-401.0
|
Capex
1 |
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/23
|
3/12/24
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
15,020
KRW Average target price
27,000
KRW Spread / Average Target +79.76% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.86% | 249M | | +9.58% | 115B | | +12.41% | 106B | | -2.59% | 21.96B | | -12.38% | 21.87B | | -5.29% | 19.21B | | -3.35% | 18.08B | | -38.57% | 17.71B | | +7.51% | 14.32B | | +35.67% | 12.42B |
Bio Therapeutic Drugs
|